Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions

Chemotherapy

Volumn 57, Issue 4, 2011, Pages 339-344

  Kielland, Live Gran ^a   Vage, Richard André ^a   Eide, Geir Egil ^a,b   Sørnes, Steinar ^a   Naess, Are ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ethambutol; Isoniazid; Neutrophil granulocyte; Phagocytosis; Pyrazinamide; Rifampicin

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DRUG EFFECT; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOCYTE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FLOW CYTOMETRY; HUMANS; ISONIAZID; NEUTROPHILS; PHAGOCYTOSIS; PYRAZINAMIDE; RESPIRATORY BURST; RIFAMPIN; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS;

EID: 80052559622     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000330442     Document Type: Article

References (28)

1. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. http://www.who.int/tb/publications/global-report/2009/pdf/full- report.pdf.
2. Appelberg R: Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol 2007; 15: 87-92. (Pubitemid 46199185)
3. Korbel DS, Schneider BE, Schaible UE: Innate immunity in tuberculosis: myths and truth. Microbes Infect 2008; 10: 995-1004.
4. Tiemessen CT, Shalekoff S, Meddows-Taylor S, Martin DJ: Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity. Clin Diagn Lab Immunol 2001; 8: 686-689. (Pubitemid 32613691)
5. Marcel N, Nahta A, Balganesh M: Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay. Chemotherapy 2008; 54: 404-411.
6. McIlleron H, Wash P, Burger A, Norman J, Folb PI, Smith P: Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients. Antimicrob Agents Chemother 2006; 50: 1170-1177.
7. Peloquin CA: Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin Chest Med 1997; 18: 79-87. (Pubitemid 27152505)
8. Okuyan B, Izzettin FV, Sancar M, Ertas O, Cevikbas A, Gurer US: Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro. Int Immunopharmacol 2005; 5: 1337-1342. (Pubitemid 40725727)
9. Naess A, Stenhaug KK, Nystad TW, Sornes S: Linezolid and human polymorphonuclear leukocyte function. Chemotherapy 2006; 52: 122-124. (Pubitemid 43760308)
10. Lehmann AK, Halstensen A, Bassoe CF: Flow cytometric quantitation of human opsonin-dependent phagocytosis and oxidative burst responses to meningococcal antigens. Cytometry 1998; 33: 406-413. (Pubitemid 28533190)
11. Sidak Z: Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 1967; 62: 626-633
12. Shalekoff S, Tiemessen CT, Gray CM, Martin DJ: Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1998; 5: 41-44. (Pubitemid 28062944)
13. Antonaci S, Jirillo E, Polignano A, Ventura MT, Sabato R, Bonomo L: Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis. Cytobios 1991; 67: 135-144.
14. Gomaa NI, Ahmed AS, El-Hadidy GS, Mansour MK: Flow cytometric analysis of the phagocytic cells in active pulmonary tuberculosis. Egypt J Immunol 2004; 11: 133-140.
15. Fahimi F, Kobarfard F, Tabarsi P, Hemmati S, Salamzadeh J, Baniasadi S: Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis referral center. Chemotherapy 2011; 57: 7-11.
16. Fiorenza G, Bottasso OA, Rateni L, Farroni MA, Dlugovitzky D: Impaired neutrophil function in patients with pulmonary tuberculosis and its normalization in those undergoing specific treatment, except the HIVcoinfected cases. FEMS Immunol Med Microbiol 2003; 35: 159-164. (Pubitemid 36298939)
17. Koshio O, Ono Y: Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase. Chemotherapy 2009; 55: 363-371.
18. Hoeprich PD, Martin CH: Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther 1970; 11: 418-422.
19. Van der Auwera P, Husson M, Fruhling J: Influence of various antibiotics on phagocytosis of Staphylococcus aureus by human polymorphonuclear leucocytes. J Antimicrob Chemother 1987; 20: 399-404. (Pubitemid 17140429)
20. Duncker D, Ullmann U: Influence of various antimicrobial agents on the chemiluminescence of phagocytosing human granulocytes. Chemotherapy 1986; 32: 18-24. (Pubitemid 16199788)
21. Hoger PH, Vosbeck K, Seger R, Hitzig WH: Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes. Antimicrob Agents Chemother 1985; 28: 667-674. (Pubitemid 16215534)
22. Labro MT, Ollivier V, Babin-Chevaye C: Interaction of rifalazil with oxidant-generating systems of human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2005; 49: 5018-5023. (Pubitemid 41778915)
23. Siegel JP, Remington JS: Effect of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis. J Antimicrob Chemother 1982; 10: 505-515. (Pubitemid 13187641)
24. Zeis BM: Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro. Chemotherapy 1988; 34: 56-60. (Pubitemid 18051986)
25. Forsgren A, Gnarpe H: The effect of antibacterial agents on the association between bacteria and leukocytes. Scand J Infect Dis Suppl 1982; 33: 115-120. (Pubitemid 13247840)
26. Pruzanski W, Saito S: Influence of agents with immunomodulating activity on phagocytosis and bactericidal function of human polymorphonuclear cells. J Rheumatol 1983; 10: 688-693. (Pubitemid 14176081)
27. Mandell LA: Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte. Rev Infect Dis 1982; 4: 683-697.
28. van den Broek PJ: Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 1989; 11: 213-245.